Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Home-Based trial tests common supplements for rare lung disease

NCT ID NCT06567717

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 26 times

Summary

This study tests whether taking zinc and nicotinamide riboside (a form of vitamin B3) twice a day for 24 weeks can improve symptoms and quality of life in people with idiopathic pulmonary fibrosis (IPF), a serious lung disease. The trial is designed to be done mostly from home, with video visits and local lung function tests, to see if this approach works for patients. Researchers will compare the supplements to a placebo and track how many people complete the study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cedars-Sinai

    RECRUITING

    Los Angeles, California, 90048, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.